The nucleic acid labeling market size has grown strongly in recent years. It will grow from $2.34 billion in 2023 to $2.55 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth observed in the historical period can be attributed to increased healthcare expenditure, a rise in research and development (R&D) spending, an increase in genomics research and disease diagnosis, heightened demand for personalized medicine, and improvements in healthcare infrastructure.
The nucleic acid labeling market size is expected to see strong growth in the next few years. It will grow to $3.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The anticipated growth in the forecast period can be attributed to the increasing health awareness among people, a growing penetration of key global players, a heightened focus on patient-centered approaches, the expansion of the biotechnology sector, and an increasing use of DNA sequencing. Key trends expected in the forecast period include advancements in tools for synthetic biology, progress in labeling techniques, the development of novel labeling techniques, innovative fluorescent dyes, and the integration of new labeling technologies in research and therapeutics.
The expected increase in infectious diseases is set to drive the growth of the nucleic acid labeling market in the future. Infectious diseases, caused by microscopic organisms such as parasites, fungi, viruses, and bacteria, spread through direct or indirect contact. Nucleic acid labeling techniques enhance the detection of infectious diseases such as tuberculosis, hepatitis, and gonorrhea, offering improved specificity, sensitivity, multiplexing capability, visualization, real-time monitoring, and automation. For example, in March 2023, the Centers for Disease Control and Prevention reported 8,300 cases of tuberculosis (TB) in the United States in 2022, reflecting a rise from 7,874 cases in 2021. The incidence of tuberculosis (TB) slightly increased to 2.5 incidents per 100,000 people in 2022. Thus, the surge in infectious diseases contributes to the growth of the nucleic acid labeling market.
The anticipated growth of the nucleic acid labeling market is also expected to be propelled by increased funding for genomic research. Funding for genomic research refers to financial resources allocated to support scientific investigations related to genomics. Such funds aid nucleic acid labeling advancement by fostering technology development, providing essential infrastructure, supporting expertise, and encouraging collaboration. For instance, the National Human Genome Research Institute received $604 million in 2020, $614 million in 2021, and $616 million in 2022, with a proposed allocation of $629 million in 2023. Additionally, in April 2021, the Biden administration allocated $1.7 billion to enhance SARS-CoV-2 variant detection, monitoring, and mitigation, emphasizing genomic sequencing infrastructure. Therefore, the increased funds for genomic research drive the growth of the nucleic acid labeling market.
A key trend gaining popularity in the nucleic acid labeling market is technological advancements. Major companies in the market are focusing on nanotechnology advancements to maintain their market positions. For instance, in January 2023, Cambridge Nucleomics, a UK-based biotechnology company, introduced a new technology called nano bait, which enables highly multiplexed detection of nucleic acid signatures caused by respiratory pathogens. This technology offers a faster solution for viral RNA detection compared to other techniques.
Major companies operating in the nucleic acid labeling market are making significant investments. Investments in nucleic acid labeling involve financial contributions to initiatives, companies, or projects related to nucleic acid labeling technologies, research, and development. In January 2023, Agilent Technologies Inc., a US-based provider of software and instruments for laboratories, invested $725 million to double its therapeutic nucleic acids production capacity. This strategic move aims to meet the growing demand for high-quality active pharmaceutical ingredients used in drugs targeting various diseases, including cancer, cardiovascular issues, and rare and infectious diseases.
In January 2023, ALS Limited, an Australia-based testing labs operator, acquired Invitek Molecular GmbH for an undisclosed sum. With this acquisition, ALS Limited aims to expand its expertise and provide in-vitro diagnostics firms worldwide with custom development and contract manufacturing services in the nucleic acid labeling market. Invitek Molecular GmbH is a Germany-based manufacturer of molecular diagnostic tools operating in the nucleic acid labeling market.
Major companies operating in the nucleic acid labeling market report are General Electric Company, F. Hoffman-La Roche AG, Thermo Fisher Scientific Inc., Merck Group, Roche Diagnostics Corporation, GE Healthcare Bio Sciences AB, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Cytiva, Qiagen N.V., Biotium Inc., Illumina Inc., LGC Group, Promega Corporation, New England Biolabs, Enzo Biochem Inc., LI-COR Biosciences Inc., Eurogentec S.A., OriGene Technologies Inc., BaseClear B.V., Vector Laboratories Inc., Bio-Synthesis Inc., BioCat GmbH, Jena Bioscience GmbH, LubioScience GmbH, GeneCopoeia Inc., Mirus Bio LLC, Daicel Arbor Biosciences.
North America was the largest region in the nucleic acid labeling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid labeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nucleic acid labeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The primary product types in nucleic acid labeling encompass kits, reagents, and instruments. Reagents refer to substances or compounds utilized in diagnostic tests or laboratory experiments to identify, analyze, or measure specific components in biological samples. Various labeling types include radioisotope or radioactive labels, non-radioactive labels, and diverse methods such as enzyme-based and chemical-based approaches. These applications find use in various techniques such as DNA sequencing, polymerase chain reaction, fluorescence in situ hybridization (FISH), microarrays, blotting, in situ hybridization, and others. Additionally, these products cater to diverse end-users including hospitals, clinics, diagnostic centers, and more.
The nucleic acid labeling market research report is one of a series of new reports that provides nucleic acid labeling market statistics, including nucleic acid labeling industry global market size, regional shares, competitors with a nucleic acid labeling market share, detailed nucleic acid labeling market segments, market trends, and opportunities, and any further data you may need to thrive in the nucleic acid labeling industry. This nucleic acid labeling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nucleic acid labeling market consists of revenues earned by entities by providing services such as radiolabeling, biotinylation, fluorescence labeling, and enzyme labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid labeling market also includes sales of labeled nucleotides, labeling kits, labeling enzymes and detection reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The nucleic acid labeling market size is expected to see strong growth in the next few years. It will grow to $3.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The anticipated growth in the forecast period can be attributed to the increasing health awareness among people, a growing penetration of key global players, a heightened focus on patient-centered approaches, the expansion of the biotechnology sector, and an increasing use of DNA sequencing. Key trends expected in the forecast period include advancements in tools for synthetic biology, progress in labeling techniques, the development of novel labeling techniques, innovative fluorescent dyes, and the integration of new labeling technologies in research and therapeutics.
The expected increase in infectious diseases is set to drive the growth of the nucleic acid labeling market in the future. Infectious diseases, caused by microscopic organisms such as parasites, fungi, viruses, and bacteria, spread through direct or indirect contact. Nucleic acid labeling techniques enhance the detection of infectious diseases such as tuberculosis, hepatitis, and gonorrhea, offering improved specificity, sensitivity, multiplexing capability, visualization, real-time monitoring, and automation. For example, in March 2023, the Centers for Disease Control and Prevention reported 8,300 cases of tuberculosis (TB) in the United States in 2022, reflecting a rise from 7,874 cases in 2021. The incidence of tuberculosis (TB) slightly increased to 2.5 incidents per 100,000 people in 2022. Thus, the surge in infectious diseases contributes to the growth of the nucleic acid labeling market.
The anticipated growth of the nucleic acid labeling market is also expected to be propelled by increased funding for genomic research. Funding for genomic research refers to financial resources allocated to support scientific investigations related to genomics. Such funds aid nucleic acid labeling advancement by fostering technology development, providing essential infrastructure, supporting expertise, and encouraging collaboration. For instance, the National Human Genome Research Institute received $604 million in 2020, $614 million in 2021, and $616 million in 2022, with a proposed allocation of $629 million in 2023. Additionally, in April 2021, the Biden administration allocated $1.7 billion to enhance SARS-CoV-2 variant detection, monitoring, and mitigation, emphasizing genomic sequencing infrastructure. Therefore, the increased funds for genomic research drive the growth of the nucleic acid labeling market.
A key trend gaining popularity in the nucleic acid labeling market is technological advancements. Major companies in the market are focusing on nanotechnology advancements to maintain their market positions. For instance, in January 2023, Cambridge Nucleomics, a UK-based biotechnology company, introduced a new technology called nano bait, which enables highly multiplexed detection of nucleic acid signatures caused by respiratory pathogens. This technology offers a faster solution for viral RNA detection compared to other techniques.
Major companies operating in the nucleic acid labeling market are making significant investments. Investments in nucleic acid labeling involve financial contributions to initiatives, companies, or projects related to nucleic acid labeling technologies, research, and development. In January 2023, Agilent Technologies Inc., a US-based provider of software and instruments for laboratories, invested $725 million to double its therapeutic nucleic acids production capacity. This strategic move aims to meet the growing demand for high-quality active pharmaceutical ingredients used in drugs targeting various diseases, including cancer, cardiovascular issues, and rare and infectious diseases.
In January 2023, ALS Limited, an Australia-based testing labs operator, acquired Invitek Molecular GmbH for an undisclosed sum. With this acquisition, ALS Limited aims to expand its expertise and provide in-vitro diagnostics firms worldwide with custom development and contract manufacturing services in the nucleic acid labeling market. Invitek Molecular GmbH is a Germany-based manufacturer of molecular diagnostic tools operating in the nucleic acid labeling market.
Major companies operating in the nucleic acid labeling market report are General Electric Company, F. Hoffman-La Roche AG, Thermo Fisher Scientific Inc., Merck Group, Roche Diagnostics Corporation, GE Healthcare Bio Sciences AB, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Cytiva, Qiagen N.V., Biotium Inc., Illumina Inc., LGC Group, Promega Corporation, New England Biolabs, Enzo Biochem Inc., LI-COR Biosciences Inc., Eurogentec S.A., OriGene Technologies Inc., BaseClear B.V., Vector Laboratories Inc., Bio-Synthesis Inc., BioCat GmbH, Jena Bioscience GmbH, LubioScience GmbH, GeneCopoeia Inc., Mirus Bio LLC, Daicel Arbor Biosciences.
North America was the largest region in the nucleic acid labeling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid labeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nucleic acid labeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The primary product types in nucleic acid labeling encompass kits, reagents, and instruments. Reagents refer to substances or compounds utilized in diagnostic tests or laboratory experiments to identify, analyze, or measure specific components in biological samples. Various labeling types include radioisotope or radioactive labels, non-radioactive labels, and diverse methods such as enzyme-based and chemical-based approaches. These applications find use in various techniques such as DNA sequencing, polymerase chain reaction, fluorescence in situ hybridization (FISH), microarrays, blotting, in situ hybridization, and others. Additionally, these products cater to diverse end-users including hospitals, clinics, diagnostic centers, and more.
The nucleic acid labeling market research report is one of a series of new reports that provides nucleic acid labeling market statistics, including nucleic acid labeling industry global market size, regional shares, competitors with a nucleic acid labeling market share, detailed nucleic acid labeling market segments, market trends, and opportunities, and any further data you may need to thrive in the nucleic acid labeling industry. This nucleic acid labeling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nucleic acid labeling market consists of revenues earned by entities by providing services such as radiolabeling, biotinylation, fluorescence labeling, and enzyme labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid labeling market also includes sales of labeled nucleotides, labeling kits, labeling enzymes and detection reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Nucleic Acid Labeling Market Characteristics3. Nucleic Acid Labeling Market Trends and Strategies32. Global Nucleic Acid Labeling Market Competitive Benchmarking33. Global Nucleic Acid Labeling Market Competitive Dashboard34. Key Mergers and Acquisitions in the Nucleic Acid Labeling Market
4. Nucleic Acid Labeling Market - Macro Economic Scenario
5. Global Nucleic Acid Labeling Market Size and Growth
6. Nucleic Acid Labeling Market Segmentation
7. Nucleic Acid Labeling Market Regional and Country Analysis
8. Asia-Pacific Nucleic Acid Labeling Market
9. China Nucleic Acid Labeling Market
10. India Nucleic Acid Labeling Market
11. Japan Nucleic Acid Labeling Market
12. Australia Nucleic Acid Labeling Market
13. Indonesia Nucleic Acid Labeling Market
14. South Korea Nucleic Acid Labeling Market
15. Western Europe Nucleic Acid Labeling Market
16. UK Nucleic Acid Labeling Market
17. Germany Nucleic Acid Labeling Market
18. France Nucleic Acid Labeling Market
19. Italy Nucleic Acid Labeling Market
20. Spain Nucleic Acid Labeling Market
21. Eastern Europe Nucleic Acid Labeling Market
22. Russia Nucleic Acid Labeling Market
23. North America Nucleic Acid Labeling Market
24. USA Nucleic Acid Labeling Market
25. Canada Nucleic Acid Labeling Market
26. South America Nucleic Acid Labeling Market
27. Brazil Nucleic Acid Labeling Market
28. Middle East Nucleic Acid Labeling Market
29. Africa Nucleic Acid Labeling Market
30. Nucleic Acid Labeling Market Competitive Landscape and Company Profiles
31. Nucleic Acid Labeling Market Other Major and Innovative Companies
35. Nucleic Acid Labeling Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Nucleic Acid Labeling Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on nucleic acid labeling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nucleic acid labeling? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:1) By Product Type: Kits; Reagents; Instruments
2) By Labeling Type: Radioisotope Or Radioactive Labels; Non-Radioactive Labels
3) By Method: Enzyme-based; Chemical-based
4) By Application: DNA Sequencing; Polymerase Chain Reaction; Fluorescence In Situ Hybridization (FISH); Microarrays; Blotting; In Situ Hybridization; Other Applications
5) By End-user: Hospitals Or Clinics; Diagnostic Centers; Other End-users
Key Companies Mentioned: General Electric Company; F. Hoffman-La Roche AG; Thermo Fisher Scientific Inc.; Merck Group; Roche Diagnostics Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned
- General Electric Company
- F. Hoffman-La Roche AG
- Thermo Fisher Scientific Inc.
- Merck Group
- Roche Diagnostics Corporation
- GE Healthcare Bio Sciences AB
- Agilent Technologies Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories Inc.
- Cytiva
- Qiagen N.V.
- Biotium Inc.
- Illumina Inc.
- LGC Group
- Promega Corporation
- Kaneka Eurogentec SA
- New England Biolabs
- Enzo Biochem Inc.
- LI-COR Biosciences Inc.
- Eurogentec S.A.
- OriGene Technologies Inc.
- BaseClear B.V.
- Vector Laboratories Inc.
- Bio-Synthesis Inc.
- BioCat GmbH
- Jena Bioscience GmbH
- LubioScience GmbH
- GeneCopoeia Inc.
- Mirus Bio LLC
- Daicel Arbor Biosciences.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | February 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 2.55 Billion |
| Forecasted Market Value ( USD | $ 3.58 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
